{"id":391201,"date":"2015-12-17T00:00:00","date_gmt":"2015-12-17T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/trtrus1115-biopharma-malignant-melanoma-treatmenttrends-us-2015-q4\/"},"modified":"2026-04-23T11:43:01","modified_gmt":"2026-04-23T11:43:01","slug":"trtrus1115-biopharma-malignant-melanoma-treatmenttrends-us-2015-q4","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/trtrus1115-biopharma-malignant-melanoma-treatmenttrends-us-2015-q4\/","title":{"rendered":"Malignant Melanoma | TreatmentTrends | US | 2015 (Q4)"},"content":{"rendered":"<p>This quarterly report series examines the current management of unresectable\/metastatic malignant melanoma in the United States from the perspective of medical oncologists and explores trends in treatment practices. It enables a greater understanding of medical practice patterns in unresectable\/metastatic malignant melanoma, segmented by BRAF-mutational status; of physicians\u2019 perceptions of drug brands, including recently launched BRAF-targeted therapies and anti-PD-1 immunotherapies, and of specific product attributes; and of the impact of sales and brand messaging efforts.<\/p>\n","protected":false},"template":"","class_list":["post-391201","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-malignant-melanoma","biopharma-geography-us","biopharma-date-717"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391201\/revisions"}],"predecessor-version":[{"id":394324,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391201\/revisions\/394324"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=391201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}